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Available online 28 August 2009Glycosaminoglycans (GAGs) presented on the surface of endothelial cells (ECs) are believed to
influence leukocyte recruitment during inflammation, but their roles remain uncertain. Here we
report an in vitro model of prolonged culture of human EC in which the contributions of heparan
sulphate (HS) and hyaluronan (HA) to the process of neutrophil recruitment could be studied.
Previously, we reported that increasing EC culture duration (up to 20 days) enhanced neutrophil
recruitment in response to low dose (1 U/ml) but not high dose (100 U/ml) of tumour necrosis
factor-α (TNF). Here we found that HS and HAwere present at much higher levels on the surface of
day 20 cultures than day 3 cultures. Neutrophil recruitment on both day 3 and day 20 ECs was
mediated through CXCR chemokine receptors and interleukin-8 (IL-8). In addition, mRNA levels
for TNF receptors, signalling pathway constituents, adhesion receptors, and chemokines involved
in neutrophil recruitment were similar for day 3 and day 20 ECs. To test whether the enhanced
neutrophil recruitment on day 20 EC was mediated by GAGs, they were removed enzymatically.
Removal of HA (but not HS) inhibited neutrophil recruitment, as did antibody blockade of CD44, a
counter-receptor for HA on neutrophils. Supernatants from hyaluronidase-treated day 20 ECs
were more potent in activating neutrophils than supernatants from untreated EC. Thus, HA has a
role in neutrophil recruitment that is revealed in long-term cultures where it increases potency of
response to sub-optimal levels of TNF. This effect appears to occur through a dual mechanism
involving chemokine presentation and interaction with CD44.
© 2009 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Vascular endothelial cells (ECs) play a major role in the regulation
of recruitment of leukocytes in inflammation. In response to
cytokines such as tumour necrosis factor (TNF) and interleukin-1
(IL-1), they upregulate expression of selectin receptors which
support capture and rolling of flowing leukocytes (reviewed by
[1]). They also synthesize and present activatory chemokines and
other chemotactic agents that induce stable adhesion between19.
Butler).
 CC BY-NC-ND license.leukocyte integrins and endothelial inter-cellular adhesion mole-
cule 1 (ICAM-1) and promote subsequent migration (reviewed by
[2,3]). There is increasing evidence that the glycosaminoglycans
(GAGs) presented in the glycocalyx of vascular endothelium play a
role in interactions with leukocytes [4,5] as well as in vascular
permeability [6] and thromboresistance [7].
GAGs are strongly negatively charged, linear sugar chains
composed of repeated sulphated and/or carboxylated disaccharide
units. There are seven forms: hyaluronan (HA), chondroitin 4-
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phate, heparin, andheparansulphate (HS) [8].With the exception of
HA, glycosaminoglycans are covalently attached to a protein
backbone to form proteoglycans [9,10]. There are a number of
studies which suggest a role for GAGs in leukocyte recruitment.
GAGs expressed on ECs have been shown to be able to bind
chemokines which may have a role in leukocyte activation,
including RANTES (CCL5), MCP-1 (CCL2), IL-8 (CXCL8), and MIP-
1α (CCL3) [11-13]. In mice producing a mutant form of HS with a
reduced ability to bind chemokines, neutrophil infiltration into
tissue in response to a number of inflammatory stimuli was
impaired [14]. In vitro, heparinase treatment of TNF-stimulated
glomerular ECs caused a reduction in the number of rolling and
firmly adherent leukocytes [15,16]. On the other hand, an earlier
study in mice showed that degradation of endothelial HS by
injection of heparitinase actually increased the number of
adherent leukocytes directly observed in venules [17]. Subsequent
infusion of heparan sulphate or heparin tended to reverse this
effect, and it was suggested that the intact glycocalyx might act as
an adhesive shield. The heparan sulphate proteoglycan syndecan-1
has been shown to regulate leukocyte binding in inflammation in
a number of studies, possibly through its presentation of HS and
modulation of integrin binding to ICAM-1 (e.g., [18,19]). In mice
lacking syndecan-1, there was increased leukocyte recruitment in
models of myocardial infarction [18] and of oxazolone-mediated
delayed-type hypersensitivity [19].
HA may also play a role in leukocyte recruitment. Administra-
tion of exogenous HA reduced neutrophil adhesion in the post-
capillary venules of the hamster cheek pouch or adhesion to TNF-
stimulated HUVEC [20]. Treatment of mice with hyaluronidase
reduced neutrophil recruitment in the cremasteric microcircula-
tion, and a similar resultwas observed inmice lacking expressionof
CD44 [21]. CD44 is the best characterised ligand of HA and is found
on leukocytes as well as ECs [4]. The interaction between CD44 on
neutrophils and HA highly expressed on the surface of ECs in liver
sinusoids was shown to play a major role in neutrophil sequestra-
tion in the liver of mice [22].
The foregoing indicates that while GAGs have the potential to
modulate leukocyte recruitment via several routes (e.g., immo-
bilising chemokines, binding leukocyte counter-receptors or
forming a physical hindrance in the glycocalyx), the importance
of each may be hard to separate, and some literature reports
appear contradictory. To study the role(s) of GAGs we took
advantage of a previously described adhesion model incorporat-
ing prolonged cultures of human umbilical vein endothelial cells
(HUVECs) [23]. HUVECs have been shown to produce and
present HS [12,24], and presentation was increased in our
long-term cultures [23]. Functionally, we found that during long-
term culture, adhesion and migration of neutrophils on HUVEC
that had been treated with low dose of TNF became more
efficient, although this potentiation was not evident with high
doses of TNF. The adhesion receptors used did not change during
prolonged culture, but activation of neutrophils became more
effective [23]. Here, comparing 3-day and 20-day cultures, we
found that HA on the endothelial surface increased as well as HS,
and it was the former rather than the latter which mediated the
increase in efficiency of recruitment of neutrophils. The
activatory chemokines utilised were similar, but HA appeared
able to present stimuli to neutrophils and also to provide a
ligand for CD44.Materials and methods
Endothelial cell culture
Human umbilical vein endothelial cells (HUVECs) were isolated
as previously described [25] and maintained in Medium 199
(M199; Invitrogen, Paisley, UK) containing 20% fetal calf serum,
28 μg/ml gentamycin, 2.5 μg/ml amphotericin B, 1 ng/ml
epidermal growth factor, and 1 μg/ml hydrocortisone (all from
Sigma-Aldrich, Poole, UK) until confluent. Primary cultures were
dissociated with trypsin/EDTA (Sigma) and passaged into tissue
culture multi-well plates (Falcon; Becton Dickinson Labware, NJ,
USA) as described [23]. Seeding density yielded confluent
monolayers within 24 hours. ECs were cultured in M199 as
above for either 3 or 20 days and then treated with TNF (0, 1,
or 100 U/ml, equivalent to 0, 50, or 5000 pg/ml; Sigma) for
4 hours prior to assay. Each experiment used first-passage ECs
from a different donor.
Neutrophil isolation
Blood was collected from healthy volunteers into K2EDTA
(Sarstedt, Leicester, UK) and used within 2 hours. Neutrophils
were isolated by centrifuging the whole blood over a 2-step
density gradient consisting of equal quantities of Histopaques
1119 and 1077 (Sigma) as described [26]. The neutrophil layer was
aspirated from the density interface and washed twice in PBS
containing 1 mM Ca2+, 0.5 mM Mg2+, and 0.15% culture-tested
bovine serum albumin (Sigma; PBS/BSA). Neutrophils were
counted using a Coulter counter (Coulter Electronics, Harpenden,
UK) and adjusted to 106/ml in PBS/BSA.
Adhesion and migration of neutrophils
ECs cultured in 6-well plates were washed with PBS/BSA to remove
TNF and placed on the stage of a phase-contrast videomicroscope
enclosed at 37 °C. An adhesion assay was performed as previously
described [23]. Briefly, neutrophils (2ml) were added (time=zero)
and allowed to settle for 5 minutes. The monolayer surface was
washed twice by gentle swirling, aspiration and replacement of PBS/
BSA, to remove non-adherent cells. A series of 5 video fields were
recorded at time=25 minutes, when transendothelial migration is
complete in this system [23]. The large-well format and brief settling
period allowed efficient washing of the central, recorded regions of
the plates, and produced very low levels of non-specific binding to
unstimulated EC but allowed high levels of adhesion to TNF-treated
EC (see Results).
The videomicroscopic recordings were analysed offline using a
computer-assisted image analysis system (ImagePro; DataCell, Finch-
ampstead, UK). Neutrophils in each field were counted, and the
averagewas taken for the repeated fields. The average was converted
to counts per squared millimeter using the known field dimensions,
multiplied by the area of the well, divided by the total number of
neutrophils added, and then multiplied by 100 to express neutrophil
adhesion as a percentage of the cells added. The adherent neutrophils
were classified into two groups (i) phase bright cells on the surface of
the endothelium and (ii) transmigrated phase dark cells that were
highly spread and migrating under the endothelial monolayer [27].
Efficiency ofmigrationwas defined as thepercentage of adherent cells
Fig. 1 – Effect of duration of EC culture on adhesion and
migration of neutrophils on ECs treated with TNF. EC were
cultured for 3 or 20 days then treated with 1 or 100 U/ml TNF
for 4 hours before analysis of (A) neutrophil adhesion
(expressed as a percentage of added cells) or (B) efficiency of
neutrophil transmigration (expressed as a percentage of
adherent cells). Data are mean±SEM from 3 or 4 experiments.
⁎⁎p<0.01, compared to day 3 by Student's t test.
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that was independent of the level of adhesion per se.
Antibody treatments
Neutrophils were treated with an Ab against CD44 (clone IM7.8.1;
gift from Aideen Long, Trinity College Dublin, The University of
Dublin) or control rat IgG (Chemicon International, CA, USA),
CXCR1 or CXCR2 (2 μg/ml both Biosource International, CA, USA),
or an isotype-matched antibody against αv-integrin (10 μg/ml;
L230; Chemicon) for 20 minutes at room temperature. Alterna-
tively neutralising monoclonal antibody (mAb) against IL-8,
epithelial neutrophil-activating peptide 78 (ENA-78), growth-
related oncogene-α (GRO-α) (all 10 μg/ml; R&D Systems,
Abingdon, UK), or an isotype-matched antibody against VCAM-1
(DakoUK Ltd., Ely, UK)was added to ECs during the last 15minutes
of TNF treatment.
Evaluation of gene expression by reverse transcriptase–
polymerase chain reaction (RT–PCR)
RNA was extracted from EC using TRIzol (Invitrogen), and reverse
transcription of single-stranded cDNA and PCR were conducted as
described [28]. Primers and PCR conditions for β-actin, E-selectin,
ICAM-1, CD31, IL-8, ENA-78, GRO-α, and P-selectin were as
previously published [29].
Quantification of EC glycosaminoglycans
Quantification of EC GAGs was performed on live ECs grown in 96-
well plates (Falcon; Becton Dickinson). Biotin-conjugated HA
binding protein (at a concentration of 1:50; Sigma) or mAbs
against HS (0.5 μg/ml; Europa Bioproducts Ltd, Ely, Cambridge)
were added to the EC monolayer for 1 hour, on ice. Cells were
washed with PBS/BSA and HRP-conjugated streptavidin or
secondary horseradish peroxidase (HRP)-conjugated, goat–anti-
mouse antibody (1:2000; Dako) was added for 1 hour, on ice, and
washed off with PBSA. Peroxidase substrate (1,2-phenylenedia-
mine dihydrochloride; Dako) was added for 7 minutes and the
reactionwas stopped by the addition of 100 μl of 1MH2SO4. ELISAs
were carried out in batches, with comparisons between culture
durations and treatments made on the same plate, to reduce assay
variation between experiments. Absorbance of the coloured
product was measured at 490 nm using a plate reader.
Enzymatic digestion of GAGs on EC
Following4hours of TNF treatment, theTNF-containingmediumwas
removed from ECs and themonolayer was rinsedwith PBS/BSA. The
monolayer was then treated with 2 ml of PBS/BSA with or without
30mU/mlheparinase (OxfordGlycosciences, Oxford,UK)or30U/ml
hyaluronidase (Sigma) for 15minutes immediatelyprior to theassay.
Supernatants were collected for use in subsequent analysis.
Neutrophil activation assay
Supernatants from hyaluronidase-treated or control EC mono-
layers were added to isolated neutrophils (2×106/ml) (1:1 ratio).
After 5minutes, neutrophil morphologywas assessed using phase-
contrast microscopy. Cells were classified as ‘resting’ if smoothlyspherical or ‘activated’ if they had undergone shape change and
had irregular outline [30].
Statistical analysis
When cultures from a particular day (day 3 or day 20) were
exposed to a single treatment, e.g., enzymatic digestion, then
results for treated cells and untreated controls were compared by
paired t test. When day 3 and day 20 cells were compared to each
other, e.g., for level of adhesion, an unpaired Student's t test was
used, as the day 3 and day 20 cells were HUVECs from different
donors and not necessarily tested on the same occasion with the
same donor of neutrophils. Effects of multiple treatments were
tested by analysis of variance (ANOVA), and when indicated, post-
hoc comparison to control was done by Dunnett's test.
The statistical analysis was carried out using Minitab software
(Minitab Ltd., Coventry, UK).Results
Effect of EC culture duration and the role of chemokines
in neutrophil recruitment
ECs maintained in culture for 20 days showed little change in
morphology or cell number, when compared to those cultured for
a shorter duration, but effects on neutrophil recruitment in
response to TNF were apparent, as previously reported [23].
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were dose-dependent changes in adhesion and migration that
were markedly influenced by the prior duration of culture.
Specifically, there was an increase in adhesion and transmigration
in response to 1 U/ml TNF on ECs cultured for 20 days, compared
to 3 days. The response to 100 U/ml was the same regardless of
culture duration (Figs. 1A and B). Very few neutrophils adhered to
unstimulated ECs, regardless of culture duration (adhesion <1%
for at least 3 experiments on each of day 3 and day 20 cultures).
We previously showed that adhesion receptors used for
attachment were similar for ECs cultured for 3 or 20 days, but
that increased recruitment of neutrophils at 20 days at 1 U/ml TNF
was attributable to increased activation and stabilisation of
adhesion [23]. We thus examined the chemokines and their
receptors operating at 1 U/ml TNF. Blockade of neutrophil
chemokine receptors CXCR1 and CXCR2 inhibited neutrophil
adhesion (Fig. 2A) and transmigration (Fig. 2B) on both 3-day
and 20-day cultures. Inhibition of transmigration was greater with
CXCR2 blockade, compared to CXCR1 (Fig. 2B). Neutralising-
antibody against IL-8 caused significant reductions in adhesion
and transmigration on both day 3 and day 20 cultures (Figs. 3A and
B). Neutralising GRO-α had no effect on adhesion or transmigra-
tion on either day 3 or day 20 cultures. Neutralising ENA-78 hadFig. 2 – Effects of blocking antibodies against CXCR1 and/or
CXCR2 on (A) adhesion or (B) transmigration of neutrophils on
ECs cultured for 3 or 20 days, prior to stimulation with 1 U/ml
TNF. Neutrophils were treated withmAb against CXCR1, CXCR2,
or an isotype-matched antibody against αv-integrin for
15 minutes prior to assay. Data are mean±SEM for 3
experiments expressed relative to untreated cells. ANOVA
showed a significant effect of treatment (p<0.01) but not of
culture duration. ⁎p<0.05, ⁎⁎p<0.01, compared to control by
Dunnett's test.
Fig. 3 – Effects of neutralising antibodies against IL-8, ENA-78,
and GRO-α on (A) adhesion or (B) transmigration of
neutrophils on ECs cultured for 3 or 20 days, prior to
stimulation with 1 U/ml TNF. ECs were treated with mAb
against IL-8, ENA-78, or GRO-α or an isotype-matched antibody
against VCAM-1 for 15 minutes prior to assay. Data are
mean±SEM for 3 experiments expressed relative to untreated
cells. ANOVA showed a significant effect of treatment (p<0.01)
but not of culture duration. ⁎p<0.05, ⁎⁎p<0.01, compared to
control by Dunnett's test.more variable effects: there was a significant effect on adhesion on
day 3 and not day 20, and a significant effect on transmigration on
day 20 and not day 3. However, combined neutralisation of ENA-
78 and IL-8 essentially abolished adhesion andmigration for either
duration of culture (Figs. 3A and B). Thus, although theremay have
been some variation between effects of individual receptors or
chemokines between culture durations, the mechanisms of
activation were similar. We conclude that from the most reliable
data, e.g., with combined antibodies, joint actions of CXCR1 and
CXCR2, and of IL-8 and ENA-78, were operative and underlie
activation for both culture durations.
Effect of culture duration on expression of ‘inflammatory’
genes
Next, we analysed levels of EC mRNA to assess whether there were
changes whichwould suggest an amplified responsiveness to 1 U/ml
TNF in ECs that had been cultured for long periods. In four
experiments, we found no consistent changes in the expression of
TNF receptors (TNFR1 and TNFR2), or transcription factors of the
NFκB/Rel family, or of the NFκB regulatory protein IκBα between day
Fig. 4 – Expression of regulators or markers of inflammation
in ECs cultured for 3 or 20 days. mRNA was isolated from
resting ECs and analysed for TNF receptors 1 and 2, IκBα and
the NFκB/Rel family of transcription factors, or from resting
or TNF-treated ECs and analysed for ICAM-1, E-selectin,
P-selectin, IL-8, GRO-α, and CD31. β-Actin is shown as a loading
control. Expression of mRNA for ENA-78 was not detectable
by this method. Gels are representative of 4 experiments.
Fig. 5 – Effect of culture duration on endothelial surface
concentrations of (A) hyaluronan or (B) heparan sulphate. ECs
were cultured for 3 or 20 days before quantification, using
biotin-conjugated HA binding protein or mAb against HS. The
effect of pre-treatment with hyaluronidase or heparinase was
also tested. Data are mean±SEM for 3 to 6 measurements.
⁎⁎p<0.05, compared to day 3 by Student's t test. +p<0.05,
++p<0.01, compared to day 20 by paired t test.
Fig. 6 – Effect of heparinase treatment of ECs on (A) adhesion or
(B) transmigration of neutrophils. ECs were cultured for
20 days, stimulated with 1 or 100 U/ml TNF for 4 hours, then
treatedwith PBS/BSAwith orwithout 30mU/ml heparinase for
30 minutes prior to assay. Adhesion and transmigration
efficiency are shown for heparinase-treated ECs relative to
untreated ECs. Data are mean±SEM from 3 experiments.
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in Fig. 4A. Although there were occasional variations between 3-day
and 20-day cultures, densitometric analysis of gel bands confirmed
that there were no significant effects of culture duration overall (data
not shown). This suggests that no change occurred in the activation
pathway for TNF. Moreover levels of expression of EC adhesion
molecules or chemokinewere similar for day3 andday20ECs treated
with 0 or 1U/ml TNF (Fig. 4B). As expected TNF treatment causedup-
regulation of mRNA, e.g., for E-selectin and IL-8, but basal and
stimulated levels were similar for day 3 and day 20 cultures.
Role of glycosaminoglycans in changes in endothelial
function
Having found no evident differences in mechanisms underlying
neutrophil adhesion and transmigration linked to culture duration,
or changes in gene expression that could explain increased
recruitment at low dose TNF, we investigated whether changes
in GAGs might have contributed. ECs which had been cultured for
3 or 20 days were assayed for surface expression of hyaluronan
(HA) or heparan sulphate (HS). On day 3 cultures, HA was just
detectable (Fig. 5A), but HS was undetectable (Fig. 5B). In limited
experiments, increasing development time of the ELISA increased
all signals but did not bring the signal for HS above the non-specific
control. Both HA and HS showed much increased expression by
day 20. The surface levels could be reduced to those at day 3 using
the enzymes hyaluronidase and heparinase, respectively (Fig. 5).
Expression levels of HA were not affected by the 4 hours of TNF
treatment used for adhesion assays (data not shown).
In order to establish whether HS or HA on day 20 cultures could
have a role in the increased recruitment of neutrophils, in response
to low doses of TNF, we treated day 20 ECs with heparinase or
hyaluronidase prior to adhesion assay. Heparinase treatment had
no effect on neutrophil adhesion or transmigration on day 20 ECs
Fig. 7 – Effect of hyaluronidase treatment of ECs on (A)
adhesion or (B) transmigration of neutrophils. ECs were
cultured for 3 or 20 days, stimulated with 1 or 100 U/ml TNF for
4 hours, then treated with PBS/BSA with or without 30 mU/ml
hyaluronidase for 30 minutes prior to the assay. Adhesion and
transmigration efficiency are shown for heparinase-treated ECs
relative to untreated ECs. Data are mean±SEM from 4
experiments. ⁎⁎p<0.01, compared to untreated by paired t test.
Fig. 8 – Effect of antibody against CD44 on (A) adhesion or
(B) transmigration of neutrophils. ECs were cultured for 3 or
20 days and stimulated with 1 or 100 U/ml TNF. Neutrophils
were treated with antibody against CD44 for 30 minutes prior
to assay. Adhesion and transmigration efficiency are shown for
antibody-treated neutrophils relative to untreated cells. Data
are mean±SEM from 3 or 4 experiments. ⁎⁎p<0.01, compared
to untreated by paired t test.
Fig. 9 – Effects of hyaluronidase on the ability of supernatants
from ECs to activate neutrophils morphologically. ECs were
cultured for 3 or 20 days and treatedwith 1 or 100 U/ml TNF for
4 hours. Mediumwas removed and replacedwith PBS/BSAwith
or without 30 mU/ml hyaluronidase for 30 minutes. The
supernatants were collected and added to neutrophils for
5 minutes and their shape change was observed using a
microscope to determine the percent activated. For
comparison, neutrophils were also treated with PBS/BSA
with or without hyaluronidase. Data are mean±SEM for 3
experiments. ⁎p<0.05, ⁎⁎p<0.01, for hyaluronidase-treated
vs. untreated by paired t test.
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treatment with hyaluronidase, adhesion to day 20 ECs stimulated
with 1 U/ml TNF was reduced to less than 50% of the untreated
(Fig. 7A). There was no effect of hyaluronidase treatment on
neutrophil recruitment to ECs stimulated with 100 U/ml TNF or to
day 3 cultures treated with either dose of TNF (Figs. 7A and B).
To test whether the HA ligand on neutrophils, CD44, played a
role in their recruitment on 20-day ECs, neutrophils were treated
with an antibody against CD44. There was no effect of antibody
treatment on the level of neutrophil adhesion to day 3 or day 20
ECs stimulated with 1 or 100 U/ml TNF (Fig. 8A). However,
antibody specifically reduced transmigration efficiency through
day 20 ECs treated with 1 U/ml TNF but not for 100 U/ml TNF or
day 3 EC (Fig. 8B). Isotype-matched control antibody had no
significant effect on either parameter (data not shown).
Neutrophil activation by supernatants from EC
Wewondered whether HA might act by presenting chemokines to
neutrophils.We took the supernatants fromhyaluronidase-treated
or untreated ECs and measured their ability to activate freshly
isolated neutrophils. ECs stimulated with TNF released soluble
mediators in the 30 minutes after removal of the TNF which were
able to activate neutrophils (Fig. 9). Activationwasmore potent for
EC treated with 100 U/ml TNF than 1 U/ml, but in the absence of
hyaluronidase treatment, the supernatants had equal activity for
3-day or 20-day cultures. However, the supernatants from day 20
cultures treated with hyaluronidase induced higher levels ofneutrophil activation than the untreated supernatants (Fig. 9).
Hyaluronidase treatment did not increase the potency of super-
natants from day 3 cultures. Nor did hyaluronidase itself increase
neutrophil activation (Fig. 9). Importantly, supernatants from the
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showing that therewas no intrinsic action of HA fragments (Fig. 9).
Thus, a neutrophil-activating ability was associated with HA for
TNF-treated EC which had been cultured for 20 days.Discussion
We have described an experimental model in which prolonged
culture of endothelial cells increases their presentation of GAGs.
This allowed us to study the contributions of heparan sulphate
and hyaluronan to the regulation of leukocyte adhesion and
migration. HA and HS were barely detectable on early cultures
of HUVECs but well expressed after 20 days of culture. On 20-
day cultures, HA promoted neutrophil recruitment induced by a
low dose of TNF, but at a higher dose, the presence of HA was
not required for an effective response. HA appeared to make the
presentation of activator(s) to neutrophils more efficient, which
was more critical at the lower level of stimulation. Put
differently, the presence of HA explained the increase in
efficiency of recruitment found in 20-day compared to 3-day
cultures responding to TNF [23]. On the other hand, HS did not
have an obvious role in neutrophil adhesion or migration in this
model, for short- or long-term cultures.
Expression of HS on HUVECs has been reported previously
[12,24]. Others did not detect HA on the surface of HUVECs after
short-term culture, but it was detected on microvascular ECs,
where expression increased after activation with agents including
TNF [31]. Here, HA expressed on our 20-day cultures was removed
by treatment with hyaluronidase but not increased by TNF
treatment. There may be intrinsic differences between specific
EC types, in terms of expression of HA and its counter-receptor
CD44. Previous studies indicated that the ability of CD44 to bind
HAwas controlled in a cell-type and activation-specific manner, so
that not all cells which expressed CD44 could bind HA [32]. This
may explain why HA is particularly important for neutrophil
recruitment in some tissues, such as the liver sinusoids, where it is
constitutively present at high levels [22].
We previously reported that as endothelial culture duration was
prolonged, efficiency of neutrophil recruitment at a low dose of TNF
was progressively increased [23]. Under flow conditions, capture of
neutrophils was not affected by culture duration (i.e., presence or
absence of GAGs on the EC surface), but neutrophil activation and
transmigration was more efficient for prolonged cultures [23]. Here
we found that the chemokine receptors CXCR1 and CXCR2 were
equally important in neutrophil recruitment on 3- or 20-day
cultures, as were the chemokines IL-8 and ENA-78. Upon studying
EC mRNA for TNF signalling pathway constituents, adhesion
receptors, and chemokines, we found no difference between day 3
and day 20 cultures. Therefore, we hypothesized that it was the
increased levels of GAGs that led to the enhanced activation of
neutrophils. Treatment of the day 20 ECs with hyaluronidase
reduced neutrophil adhesion in response to low levels of TNF,
whereas treatment with heparinase had no effect. Hyaluronidase
treatment of day 20 TNF-stimulated ECs also yielded supernatants
that were more potent neutrophil activators than untreated
supernatants. This enzyme-potentiated activity was not evident
for day 3 cultures or for unstimulated day 20 cultures. The latter
ruled out intrinsic activating effects of HA fragments. Thus, it
seems that HA may bind and improve efficiency of presentation ofchemokines to neutrophils. Such a concept is consistent with in
vivo studies where intravenous injection of HA inhibited firm
adhesion (but not rolling) of neutrophils in post-capillary venules
of the hamster cheek pouch [20], perhaps by competing with HA
on the endothelial surface.
In our studies, the effect of HA digestion was only seen at the
lower concentration of TNF, suggesting that HA was not necessary
for efficient neutrophil recruitment at the higher concentration. In
response to high levels of stimulation, such as 100 U/ml TNF, the
ECs produce very large quantities of chemokines that presumably
do not need to be presented by GAGs to have a physiological effect
on neutrophils. Indeed, day 3 cultures were capable of recruiting
neutrophils at a high level of stimulation, despite having a low
concentration of GAGs on their surface. The day 3 cultures did not
efficiently recruit neutrophils after a lower level of stimulation,
perhaps because they did not efficiently present chemokines via
GAGs. In vivo, one would expect ECs to have an intact glycocalyx
and to be exposed to levels of stimulation closer to 1 U/ml TNF. As a
guide, TNF can be detected in the serumof patientswith tumours at
levels up to about 50 pg/ml (equivalent to 1 U/ml for the TNF used
here) [33–35] or 250 pg/ml immediately after injection of
Escherichia coli endotoxin [36]. The long-term cultures used here
generated a basement membrane that is lacking in short-term
cultures [23] and were quiescent in the sense that they did not
recruit flowing leukocytes unless treated with TNF. Thus, we
propose that the 20-day ‘endothelium’ and the lower dose of TNF
are particularly relevant to inflammation in vivo and that our
results suggest a hitherto unexpected role for HA under such
conditions.
Treatment of neutrophils with antibody against CD44, the
major ligand for HA, reduced neutrophil recruitment under the
same circumstances as treatment of EC with hyaluronidase; for
day 20 but not day 3 ECs, and only for a low dose of TNF. However,
the antibody reduced transmigration rather than adhesion itself.
Thus, while its effect relied on the presence of HA, the loss of
CD44–HA interaction inhibited the later stage of migration but did
not disrupt neutrophil activation so as to reduce stable attachment
itself. On the other hand, completely removing HA caused this pro-
adhesive signal to be lost. Neither type of interaction was
necessary at high levels of TNF. Evidence for distinct actions of
endothelial HA and neutrophil CD44 is available from studies of
neutrophil recruitment in venules of mice lacking CD44 (either
totally, on their EC or on the neutrophils) or treated with
hyaluronidase [21]. Lack of CD44 on EC or treatment with
hyaluronidase caused loss of stable adhesion in venules compared
to untreated WT mice, while hyaluronidase treatment had no
further effect on mice already lacking CD44. On the other hand, if
only neutrophils lacked CD44 (achieved by transplantation of
CD44-negative bone marrow into wild-type mice) adhesion was
maintained but migration into tissue was reduced. Thus, endo-
thelial HA increased efficiency of adhesion, while neutrophil
CD44–HA interaction increased transmigration of adherent cells.
While many cell lines that express CD44 can bind HA, resting
leukocytes cannot [37,38]. For monocytes at least, activation with
inflammatory cytokines such as TNF and IL-1 induced CD44–HA
binding [39]. Restingmurine neutrophils could not bind to HA [21],
and thus, an initial interaction with chemokines may be required
for CD44–HA binding.
Based on the above, we suggest that, in our model, neutrophils
binding to ECs became activated and firmly adherent through the
3440 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 5 ( 2 0 0 9 ) 3 4 3 3 – 3 4 4 1action of surface-presented chemokines (which was promoted by
HA), and this enabled a later stage of CD44–HA binding that
facilitated transmigration. To seek direct evidence that HA on day 20
ECs did present chemokines, we assayed IL-8 in endothelial super-
natants and whole cell lysates (with and without hyaluronidase
digestion) after treatmentwith TNF. However, althoughwe did tend
to find less free IL-8 in day 20 than day 3 supernatants, we did not
detect a compensatory greater level in whole cell lysates or in
hyaluronidase digests from the surface (data not shown). In our
experience,HUVECsproduceand release plentiful IL-8, and it is likely
that only a very small proportion is retained and functionally active
at the cell surface in any case. Our sandwich ELISA assay may not
havebeensensitive enough todetect small changes in concentration.
The direct detection of chemokine binding on the surface of EC is
problematic and typically requires electron microscopy or radioim-
munoassay (e.g., [40,41]). In the absence of definitive evidence, it is
also worth considering other mechanisms by which HA may have
modulated neutrophil binding here. HS bound to syndecan-1 has
been found tomodulate leukocyte integrin binding to ICAM-1 [19]. It
is possible that HS bound to CD44 could also affect stable adhesion in
such a way, although in the case noted above, the effect of the
proteoglycan was inhibitory. A positive signal might alternatively
arise from signalling through HA binding to neutrophil CD44, which
has been shown previously to increase cytokine production and cell
motility [42,43]. The exact mode of action of HA and the possible
effects of binding to CD44 on interaction with endothelium thus
require further clarification.
To our knowledge, this is the first report of a role for HA in
recruitment of human leukocytes to EC. It suggests two contribu-
tions: through improved activation of neutrophils and subsequent
action as a receptor for CD44. The restricted circumstances under
which effects were detectable (long-term culture and relatively
low dose TNF) explain why such roles have not been detected
before but are likely to be relevant to inflammatory responses in
vivo, as suggested by analogous intravital observations in mice
[21]. Althoughwe also found HS detectable in greater quantities on
long-term cultures, there was no effect of heparinase treatment on
neutrophil adhesion or migration. Others found inhibition of
neutrophil adhesion to short-term cultures of glomerular EC after
heparinase treatment [15,16]. Impairment of sulphation of HS in
mice was associated with reduced recruitment of neutrophils into
inflamed tissue [14], but in a separate study using direct
observations of inflamed venules, neutrophil adhesion actually
increased after enzymatic digestion of HS [17]. Thus, while there is
mounting evidence that GAGs fulfill important roles in leukocyte
recruitment in inflammation, contributions may be site- or
stimulus-specific. It is also apparent that variations in culture
conditions in vitro can alter the ability of ECs to recruit leukocytes.
Previously we found that long-term culture also induced deposi-
tion of a distinct basement membrane that altered behaviour of
migrated neutrophils [23]. Thus, recapitulating responses and
mediators operating in vivo can be difficult experimentally, and
care must be taken in generalising results obtained in vitro.Acknowledgments
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